Vol.69 No.3 May 2021

Changes in the pattern of use of oral third-generation cephalosporins and their association with the outcomes of ophthalmic day surgeries

Eriko Kuramoto, Nobuyuki Muroi, Masaki Hirabatake, Haruna Hirayama, Naoki Shibatani, Asako Doi, Yasuo Kurimoto and Tohru Hashida

Jpn. J. Chemother. 69 (3): 249-254, 2021

Phase III double-blind comparative study of intravenous lascufloxacin and levofloxacin in patients with community-acquired pneumonia

Makoto Miki, Keiichi Mikasa, Junichi Kadota, Hiroshi Mukae, Jiro Fujita, Katsunori Yanagihara, Kazuhiro Tateda, Kyoichi Totsuka, Yasuko Umemoto, Sayoko Tanioka and Shigeru Kohno

Jpn. J. Chemother. 69 (3): 255-269, 2021

Open-label study of intravenous lascufloxacin for secondary infections in patients with chronic pulmonary diseases, aspiration pneumonia and lung abscess

Makoto Miki, Keiichi Mikasa, Junichi Kadota, Hiroshi Mukae, Jiro Fujita, Katsunori Yanagihara, Kazuhiro Tateda, Kyoichi Totsuka, Tomohiko Eiraku and Shigeru Kohno

Jpn. J. Chemother. 69 (3): 270-285, 2021

Ceftriaxone-induced encephalopathy occurring during hemodialysis: a case report

Yuki Nakano, Shigehisa Mizuta, Hisao Otakeno, Taichi Matsumoto, Keisuke Migita, Shuji Hara and Kenjo Yokoo

Jpn. J. Chemother. 69 (3): 286-292, 2021